In
order to strengthen the research activity in the anti-infective
areas, a well-equipped state-of-the-art Bio Safety Level
–3 facility has been established. This is specially designed
negatively air pressured containment facility meeting
the Bio Safety Level-3 requirements as per the guidelines
of Centre for Diseases Control (CDC), Atlanta for handling
hazard group III pathogens. IIIM is one of the five CSIR
labs having this facility which is being formally commissioned
in April 2006. This facility will strengthen the research
activity in the ongoing anti TB and molecular targets
projects of M tuberculosis. Screening of phytomolecules
for anti HIV activity, vaccines and vaccines adjuvant
are the other areas that will be taken into the research
scaffold of the institute. Apart from the in house research
activities, this facility will also cater as Regional
Center for providing diagnostics in case of outbreaks.
|